| Typicality: | 0.202 |
| Saliency: | 0.094 |
| in our pharmaceuticals pipeline | 9 | transitive-object |
| visibility → help support → further investment | 3 |
| visibility → support → further investment | 3 |
| negative | neutral | positive |
| 0.002 | 0.248 | 0.750 |
| Raw frequency | 6 |
| Normalized frequency | 0.094 |
| Modifier score | 0.500 |
| Perplexity | 192.144 |